Keegan Mark T, Goldberg Michael E, Torjman Marc C, Coursin Douglas B
Mayo Clinic, Rochester, Minnesota, USA.
J Diabetes Sci Technol. 2009 Nov 1;3(6):1288-91. doi: 10.1177/193229680900300608.
Patients with dysglycemia related to known or unrecognized diabetes, stress hyperglycemia, or hypoglycemia in the presence or absence of exogenous insulin routinely require care during the perioperative period or critical illness. Recent single and multicenter studies, a large multinational study, and three meta-analyses evaluated the safety of routine tight glycemic control (80-110 mg/dl) in critically ill adults. Results led to a call for more modest treatment goals (initiation of insulin at a blood glucose >180 mg/dl with a goal of approximately 150 mg/dl). In this symposium, an international group of multidisciplinary experts discusses the role of tight glycemic control, glucose measurement technique and its accuracy, glucose variability, hypoglycemia, and innovative methods to facilitate glucose homeostasis in this heterogeneous patient population.
患有与已知或未识别的糖尿病、应激性高血糖或低血糖相关的血糖异常（无论是否存在外源性胰岛素）的患者，在围手术期或危重病期间通常需要护理。最近的单中心和多中心研究、一项大型跨国研究以及三项荟萃分析评估了危重症成人常规严格血糖控制（80-110mg/dl）的安全性。结果促使人们呼吁采用更适度的治疗目标（血糖>180mg/dl时开始使用胰岛素，目标约为150mg/dl）。在本次研讨会上，一组国际多学科专家讨论了严格血糖控制的作用、血糖测量技术及其准确性、血糖变异性、低血糖以及促进这一异质性患者群体血糖稳态的创新方法。
